<?xml version='1.0' encoding='utf-8'?>
<document id="10773331"><sentence text="Leakage of enteric (Eudragit L)-coated dosage forms in simulated gastric juice in the presence of poly(ethylene glycol)."><entity charOffset="98-118" id="DDI-PubMed.10773331.s1.e0" text="poly(ethylene glycol" /></sentence><sentence text="Poly(methacrylic acid) (PMAA) and related copolymers strongly interact with poly(ethylene glycol) (PEG) in acidic fluids"><entity charOffset="0-22" id="DDI-PubMed.10773331.s2.e0" text="Poly(methacrylic acid)" /><entity charOffset="24-28" id="DDI-PubMed.10773331.s2.e1" text="PMAA" /><entity charOffset="76-96" id="DDI-PubMed.10773331.s2.e2" text="poly(ethylene glycol" /><entity charOffset="99-102" id="DDI-PubMed.10773331.s2.e3" text="PEG" /><pair ddi="false" e1="DDI-PubMed.10773331.s2.e0" e2="DDI-PubMed.10773331.s2.e0" /><pair ddi="false" e1="DDI-PubMed.10773331.s2.e0" e2="DDI-PubMed.10773331.s2.e1" /><pair ddi="false" e1="DDI-PubMed.10773331.s2.e0" e2="DDI-PubMed.10773331.s2.e2" /><pair ddi="false" e1="DDI-PubMed.10773331.s2.e0" e2="DDI-PubMed.10773331.s2.e3" /><pair ddi="false" e1="DDI-PubMed.10773331.s2.e1" e2="DDI-PubMed.10773331.s2.e1" /><pair ddi="false" e1="DDI-PubMed.10773331.s2.e1" e2="DDI-PubMed.10773331.s2.e2" /><pair ddi="false" e1="DDI-PubMed.10773331.s2.e1" e2="DDI-PubMed.10773331.s2.e3" /><pair ddi="false" e1="DDI-PubMed.10773331.s2.e2" e2="DDI-PubMed.10773331.s2.e2" /><pair ddi="false" e1="DDI-PubMed.10773331.s2.e2" e2="DDI-PubMed.10773331.s2.e3" /></sentence><sentence text=" Due to the in vitro experiments presented in this paper, there is a clear indication for a drug-drug interaction in vivo between PEG solutions, e"><entity charOffset="130-133" id="DDI-PubMed.10773331.s3.e0" text="PEG" /></sentence><sentence text="g" /><sentence text=", commercially available laxatives, and dosage forms with PMAA-based enteric-coatings (Eudragit L)"><entity charOffset="58-60" id="DDI-PubMed.10773331.s5.e0" text="PMAA" /></sentence><sentence text=" In these studies, enteric-coated tablets did not fulfil the pharmacopoeias' criteria of the disintegration test if PEGs were present in the simulated gastric juice"><entity charOffset="116-119" id="DDI-PubMed.10773331.s6.e0" text="PEG" /></sentence><sentence text=" Drug substances which are known to be unstable in acidic media or which can cause gastric irritation were released from their enteric-coated dosage forms in acidic PEG media (pH 1)"><entity charOffset="165-168" id="DDI-PubMed.10773331.s7.e0" text="PEG" /></sentence><sentence text=" Various drug dosage forms, single and multiple unit systems, were tested" /><sentence text=" They show higher and faster drug release in the presence of PEG"><entity charOffset="61-64" id="DDI-PubMed.10773331.s9.e0" text="PEG" /></sentence><sentence text=" To get insight into the mechanism of the interaction, experiments and theoretical calculations were performed which reveal that PEGs with high molecular weight show stronger interactions with PMAA coatings indicating a contribution of hydrophobic interactions to the occurring intermolecular forces"><entity charOffset="193-195" id="DDI-PubMed.10773331.s10.e0" text="PMAA" /><entity charOffset="129-131" id="DDI-PubMed.10773331.s10.e1" text="PEG" /><pair ddi="false" e1="DDI-PubMed.10773331.s10.e1" e2="DDI-PubMed.10773331.s10.e1" /><pair ddi="false" e1="DDI-PubMed.10773331.s10.e1" e2="DDI-PubMed.10773331.s10.e0" /></sentence><sentence text=" Hydrogen bonds can be build between each monomeric unit of PEG and the acidic sequences of the copolymer"><entity charOffset="1-9" id="DDI-PubMed.10773331.s11.e0" text="Hydrogen" /><entity charOffset="60-63" id="DDI-PubMed.10773331.s11.e1" text="PEG" /><pair ddi="false" e1="DDI-PubMed.10773331.s11.e0" e2="DDI-PubMed.10773331.s11.e0" /><pair ddi="false" e1="DDI-PubMed.10773331.s11.e0" e2="DDI-PubMed.10773331.s11.e1" /></sentence><sentence text="" /></document>